Jim Cramer on CVS: “I Would Argue That It’s Cheaper”

CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer shared his thoughts on as he discussed Big Tech’s AI spending. Cramer discussed the company’s “great” quarter during the episode, as he said:

In Friday night’s game plan, I told you to expect a great quarter from CVS Health, and that’s exactly what we got this very morning. CVS also owns Aetna, a huge health insurance company, and Caremark, the number one pharmacy benefit manager. Today, they reported a magnificent 39 cent earnings beat of $2.18 basis with higher than expected revenue, and management raised their full year forecast pretty substantially. As a result, the stock shot up 7.7% today, reaching a three-year high… The stock went up a lot, but the earnings went up, so it’s not more expensive. I would argue that it’s cheaper.

CVS Health Corporation (NYSE:CVS) provides healthcare solutions through insurance, pharmacy benefit management, and retail pharmacy services.

While we acknowledge the potential of CVS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years

Disclosure: None. Follow Insider Monkey on Google News.